Management Algorithm For mild HS (low IHS4), topical 15% resorcinol has been evaluated in small prospective and long-term studies, showing reductions in pain, lesion size and IHS4 scores, albeit with irritant dermatitis in some patients [83,84,85], while a randomized, double-blind, placebo-controlled pilot trial of botulinum toxin type B and emerging series with botulinum toxin type A have demonstrated meaningful improvements in pain, suppuration and QoL, particularly in patients with concomitant hyperhidrosis [86, 87]
it is not a health device, he says
Now throughout our fun family activities that included making our ornaments and devouring this delicious pizza, we filled our glasses with ice and Coca-Cola
The FTI report found consumption of illicit tobacco in New Zealand increased 37 percent in 2023, even as overall consumption declined